1
项与 Melan-A analog peptide + Tyrosinase YMD peptide Vaccine Adjuvanted with CpG and Montanide(Centre Hospitalier Universitaire Vaudois) 相关的临床试验Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients With CpG7909, Tumor Antigenic Peptides and Montanide
The purpose of this study is to determine whether vaccination with tumor antigenic peptides and both CpG and Montanide adjuvants can induce an immune response in melanoma patients and to assess the safety of this vaccination.
100 项与 Melan-A analog peptide + Tyrosinase YMD peptide Vaccine Adjuvanted with CpG and Montanide(Centre Hospitalier Universitaire Vaudois) 相关的临床结果
100 项与 Melan-A analog peptide + Tyrosinase YMD peptide Vaccine Adjuvanted with CpG and Montanide(Centre Hospitalier Universitaire Vaudois) 相关的转化医学
100 项与 Melan-A analog peptide + Tyrosinase YMD peptide Vaccine Adjuvanted with CpG and Montanide(Centre Hospitalier Universitaire Vaudois) 相关的专利(医药)
100 项与 Melan-A analog peptide + Tyrosinase YMD peptide Vaccine Adjuvanted with CpG and Montanide(Centre Hospitalier Universitaire Vaudois) 相关的药物交易